New strategies in behavioural phenotyping research: from individual domains to modeling domain...

1
BioMed Central Page 1 of 1 (page number not for citation purposes) Annals of General Psychiatry Open Access Oral presentation New strategies in behavioural phenotyping research: from individual domains to modeling domain networks Allan V Kalueff Address: Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, USA Stress plays a key role in pathogenesis of anxiety and depression. Animal models of these disorders are widely used in behavioral neuroscience to explore stress-evoked brain abnormalities, screen anxiolytic/antidepressant drugs and establish behavioral phenotypes of gene-tar- geted or transgenic animals. Here we discuss the current situation with these experimental models, and critically evaluate the state of the art in this field. Noting a deficit of fresh ideas and especially new paradigms for animal anx- iety and depression models, we review existing challenges and outline important directions for further research in this field. Potential strategies for the development of new animal paradigms include 1) modeling different subtypes of anxiety and depression, 2) their common pathogenesis, 3) the use of a wider spectrum of parameters, techniques and model objects. With psychiatric nomenclature and diagnostic criteria subject to constant modifications and reconsiderations, we may also benefit from 4) targeting a wider cluster of related behavioral phenomena (e.g., obsessive-compulsive disorders, Tourette's syndrome, addiction), 5) expanding models beyond traditional “anxiety” and “depression” domains, and 6) using “hybrid” models and tests. Together, these approaches will allow a better focus on the neurobiology of stress, enabling further integrative modeling of mood, behavio- ral and personality disorders consistent with recent trends and paradigmal shifts in modern psychiatry. One of the main reasons to invest time and efforts into new “integra- tive” models of anxiety and depression is the possibility to discover new agents or even principally new classes of psy- chotropic drugs, the need for which has long been recog- nized. In addition, this approach will increase our understanding of pathogenesis of anxiety and depression, and the link between these disorders and other brain ill- nesses. from International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour Thessaloniki, Greece. 28 November – 2 December 2007 Published: 17 April 2008 Annals of General Psychiatry 2008, 7(Suppl 1):S26 doi:10.1186/1744-859X-7-S1-S26 <supplement> <title> <p>International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour</p> </title> <note>Meeting abstracts - A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1744-859X-7-S1-full.pdf">here</a>.</note> </supplement> This abstract is available from: http://www.annals-general-psychiatry.com/content/7/S1/S26 © 2008 Kalueff; licensee BioMed Central Ltd.

Transcript of New strategies in behavioural phenotyping research: from individual domains to modeling domain...

BioMed Central

Page 1 of 1(page number not for citation purposes)

Annals of General Psychiatry

Open AccessOral presentationNew strategies in behavioural phenotyping research: from individual domains to modeling domain networksAllan V Kalueff

Address: Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD, USA

Stress plays a key role in pathogenesis of anxiety anddepression. Animal models of these disorders are widelyused in behavioral neuroscience to explore stress-evokedbrain abnormalities, screen anxiolytic/antidepressantdrugs and establish behavioral phenotypes of gene-tar-geted or transgenic animals. Here we discuss the currentsituation with these experimental models, and criticallyevaluate the state of the art in this field. Noting a deficit offresh ideas and especially new paradigms for animal anx-iety and depression models, we review existing challengesand outline important directions for further research inthis field. Potential strategies for the development of newanimal paradigms include 1) modeling different subtypesof anxiety and depression, 2) their common pathogenesis,3) the use of a wider spectrum of parameters, techniquesand model objects. With psychiatric nomenclature anddiagnostic criteria subject to constant modifications andreconsiderations, we may also benefit from 4) targeting awider cluster of related behavioral phenomena (e.g.,obsessive-compulsive disorders, Tourette's syndrome,addiction), 5) expanding models beyond traditional“anxiety” and “depression” domains, and 6) using“hybrid” models and tests. Together, these approacheswill allow a better focus on the neurobiology of stress,enabling further integrative modeling of mood, behavio-ral and personality disorders consistent with recent trendsand paradigmal shifts in modern psychiatry. One of themain reasons to invest time and efforts into new “integra-tive” models of anxiety and depression is the possibility todiscover new agents or even principally new classes of psy-chotropic drugs, the need for which has long been recog-nized. In addition, this approach will increase ourunderstanding of pathogenesis of anxiety and depression,and the link between these disorders and other brain ill-nesses.

from International Society on Brain and Behaviour: 3rd International Congress on Brain and BehaviourThessaloniki, Greece. 28 November – 2 December 2007

Published: 17 April 2008

Annals of General Psychiatry 2008, 7(Suppl 1):S26 doi:10.1186/1744-859X-7-S1-S26

<supplement> <title> <p>International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour</p> </title> <note>Meeting abstracts - A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1744-859X-7-S1-full.pdf">here</a>.</note> </supplement>

This abstract is available from: http://www.annals-general-psychiatry.com/content/7/S1/S26

© 2008 Kalueff; licensee BioMed Central Ltd.